Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04592978 · ClinicalTrials.gov registry record · NA
Personalized Feedback Intervention for Alcohol and Opioid Use Among Adults With Chronic Pain
A NA study, sponsored by Syracuse University.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
NCT04592978 is a NA study that has completed, run by Syracuse University. The registered enrollment target is 206 participants.
The verdict
NCT04592978, a NA study, has completed, sponsored by Syracuse University.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
Study Summary
Over one-quarter of American adults engage in hazardous drinking (i.e., a pattern of alcohol consumption that increases risk for harmful consequences), which is the third leading cause of preventable death in the U.S. Rates of hazardous drinking are significantly higher among individuals with (vs. without) chronic pain. Moreover, 20% of individuals prescribed opioids endorse concurrent alcohol and opioid use, which may interfere with chronic pain treatment and lead to dangerous/potentially fatal health effects. No interventions to date have targeted either hazardous drinking or concurrent use of alcohol and opioids in the context of chronic pain. The current four-year R01 builds upon our past work by developing a brief, single-session, computer-based, personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse pain-alcohol-opioid interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding concurrent use of alcohol and prescription opioid medications. Specifically, we will develop an integrated PFI for hazardous drinkers with chronic pain who are prescribed opioids (PA-PFI). Our approach will follow a staged model consistent with NIH guidelines for developing and standardizing behavioral interventions. Phase IA activities will involve collecting qualitative and quantitative feedback from three iterative focus groups (N = 21) to refine intervention content and evaluate treatment acceptability and feasibility. Phase IB activities will include a proof-of-concept and highly rigorous randomized clinical trial designed to compare PA-PFI to control PFI (C-PFI) among a sample of 174 hazardous drinkers with chronic pain who are currently prescribed opioid medications. This study represents an important and pivotal step in the larger landscape of translating basic research to more efficacious strategies for reducing hazardous drinking among underserved populations with medica
Interventions
- BEHAVIORAL Control Personalized Feedback Intervention
- BEHAVIORAL Pain-Alcohol Personalized Feeback Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2021-07-30 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04592978
The ClinicalTrials.gov registry entry for NCT04592978 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syracuse University, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Personalized Feedback Intervention is the first listed.
NCT04592978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04592978 about?
NCT04592978 is a clinical study titled "Personalized Feedback Intervention for Alcohol and Opioid Use Among Adults With Chronic Pain". Over one-quarter of American adults engage in hazardous drinking (i.e., a pattern of alcohol consumption that increases risk for harmful consequences), which is the third leading cause of preventable death in the U.S. Rates of hazardous drinking are significantly higher among individuals with (vs. w...
What is the current status of trial NCT04592978?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2021-07-30. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT04592978?
The interventions under investigation include: Control Personalized Feedback Intervention (BEHAVIORAL), Pain-Alcohol Personalized Feeback Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04592978?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.